Ophthalmology Times

Ophthalmology Times is a publication created by doctors for doctors, providing timely and precise news and insights related to clinical practices, socioeconomic issues, and political developments relevant to the eye care community.

National, Trade/B2B

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#356664

United States

#142609

Health/Medicine

#1168

Traffic sources

Monthly visitors

Articles

CIME 2025 unveils a galaxy of innovation in modern eye care

5 days ago | ophthalmologytimes.com | Sheryl Stevenson

As the 19th Annual Controversies in Modern Eye Care (CIME) conference approaches on May 4 at the Sheraton Grand Los Angeles, California, cochair Neda Shamie, MD, sat down with Ophthalmology Times and Optometry Times® to discuss this year’s agenda. Alongside cochairs Robert Maloney, MD, and Arjan Hura, MD, of the Maloney-Shamie-Hura Vision Institute, Shamie will lead discussions on the latest advancements and controversies in eye care, focusing on the collaborative care model.
Aflibercept: Applications for dosing duration and additional indications pending decision with FDA and EMA

1 week ago | ophthalmologytimes.com | Sydney M Crago

Regeneron has proposed a longer dosing duration for the high-dose (HD) formulation of aflibercept (EYLEA HD).
Impact of social media intervention on follow-up for patients with congenital ectopic lentis

1 week ago | ophthalmologytimes.com | Lynda Charters

A new Chinese report recognized that social media smartphone application–based interventions significantly improved follow-up adherence and increased parental knowledge among families of children with congenital ectopic lentis,1 according to Yiyuan Ma, MD, who is from the State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular...
AI reading label system enhances retinal disease diagnosis and training in ophthalmology

1 week ago | ophthalmologytimes.com | Lynda Charters

A new Chinese study reported that an artificial intelligence (AI) reading label system was found to enhance the diagnostic accuracy of retinal diseases among ophthalmologists and holds potential for integration into future medical education,1 according to first author Meng Wang, MD, from the Department of Ophthalmology, Peking Union Medical College Hospital, and the Beijing Key Laboratory of Fundus Diseases Intelligent Diagnosis & Drug/Device Development and Translation, both in Beijing.
Study finds geographic and institutional disparities for DR and DME clinical trials

1 week ago | ophthalmologytimes.com | Sydney M Crago

Results showed an unequal distributions of these clinical trials among rural and low-income populations.
Vantage Biosciences doses first patient in phase 2 study of VX-01, oral therapy for non-proliferative diabetic retinopathy

1 week ago | ophthalmologytimes.com | Martin Harp

VX01-DR-201, is a phase 2, multi-center, double-masked, randomized, placebo-controlled study in patients with moderate to severe NPDR without center-involved diabetic macular edema (CI-DME).
Oculis completes enrollment in Phase 3 DIAMOND-1 and DIAMOND-2 trials for DME eye drop candidate

1 week ago | ophthalmologytimes.com | Sydney M Crago

Topline data from both Phase 3 trials is expected in the second quarter of 2026, with NDA submission to follow thereafter.
Harrow expands VEVYE Access for All program to Klarity-C patients

1 week ago | ophthalmologytimes.com | Emily Kaiser Maharjan

Harrow is expanding its VEVYE Access for All campaign to include patients who use compounded cyclosporine 0.1% (Klarity-C, ImprimisRx) for dry eye and are interested in switching to cyclosporine ophthalmic solution 0.1% (VEVYE, Harrow). With this program, patients who use Klarity-C can convert their prescription to VEVYE for a flat rate of $59 per bottle, including refills.
Novel multistage model enhances OCT GA segmentation

2 weeks ago | ophthalmologytimes.com | Lynda Charters

A novel optical coherence tomography (OCT) retinal geographic atrophy (GA) segmentation method has been proposed by a research team from China that uses a multistage 2-branch network structure. According to coauthors Xiaoming Liu, PhD, and Jieyang Li, PhD, from the Wuhan University of Science and Technology, Wuhan, China, this method was shown to be more effective than other methods used for the GA segmentation task and for foveal avascular zone (FAZ) segmentation.
Relationship between fasting C-peptide and diabetic retinopathy in patients with type 2 diabetes mellitus

2 weeks ago | ophthalmologytimes.com | Lynda Charters

A team of Chinese researchers reported that fasting C-peptide (FCP) has a complicated relationship with the development of diabetic retinopathy (DR). Below a specific threshold, FCP exerts a protective effect, but above that threshold the protective effect becomes uncertain, according to Jicai Ma, MD, and colleagues from the Department of Endocrinology, The Second Hospital of Jilin University, Changchun, Jilin, People’s Republic of China.